The Society for Immunotherapy of Cancer (SITC) hosted the “Primer on Tumor Immunology and Cancer Immunotherapy™” during the 35th Anniversary Annual Meeting & Pre-Conference Programs on November 10, 2020. Available here are the presentation slides and video from “Session I: Generating Anti-Tumor Immunity,” as permitted by presenters.
Program Summary
The understanding of cancer immunobiology has increased dramatically in recent years, leading to the successful development of novel immune-based treatment options to improve cancer patient outcomes. The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer. New this year, the Primer on Tumor Immunology and Cancer Immunotherapy™ also touched on emerging therapies and technologies to ensure attendees at all levels stay updated in our expanding field, while also laying a comprehensive foundational base for all SITC 2020 attendees.
Program Organizers
To view the entire program schedule (including presenter permission to post) please click here.
Meeting: Primer on Tumor Immunology and Cancer Immunotherapy™; Session I: Generating Anti-Tumor Immunity; Presenter: Dmitry I. Gabrilovich, MD, PhD – AstraZeneca; Date: November 10, 202000:28:09
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us